Combined treatment using repurposed synthetic peptide desmopressin and bevacizumab as a potential antiangiogenic strategy in osteosarcoma
- DOI
- 10.3389/fmed.2026.1864843
- Published
- 2026-07-01
- Container
- Frontiers in Medicine
- Publisher
- Frontiers Media SA
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.3389/fmed.2026.1864843,
title = {Combined treatment using repurposed synthetic peptide desmopressin and bevacizumab as a potential antiangiogenic strategy in osteosarcoma},
author = {Luisina María Solernó and Candela Llavona and Zahira Yasmine Saud and Mariana Carolina Onassis and María Florencia Gottardo and Martín Manuel Ledesma and Daniel Fernando Alonso and Juan Garona},
year = {2026},
journal = {Frontiers in Medicine},
doi = {10.3389/fmed.2026.1864843},
url = {https://doi.org/10.3389/fmed.2026.1864843}
}RIS
TY - JOUR TI - Combined treatment using repurposed synthetic peptide desmopressin and bevacizumab as a potential antiangiogenic strategy in osteosarcoma AU - Luisina María Solernó AU - Candela Llavona AU - Zahira Yasmine Saud AU - Mariana Carolina Onassis AU - María Florencia Gottardo AU - Martín Manuel Ledesma AU - Daniel Fernando Alonso AU - Juan Garona PY - 2026 JO - Frontiers in Medicine DO - 10.3389/fmed.2026.1864843 UR - https://doi.org/10.3389/fmed.2026.1864843 ER -
APA
Solernó, L. M., Llavona, C., Saud, Z. Y., Onassis, M. C., Gottardo, M. F., Ledesma, M. M., Alonso, D. F., & Garona, J. (2026). Combined treatment using repurposed synthetic peptide desmopressin and bevacizumab as a potential antiangiogenic strategy in osteosarcoma. Frontiers in Medicine. https://doi.org/10.3389/fmed.2026.1864843
Source records
- crossref · retrieved 2026-09-25T07:52:02.235Z